Reevaluation of the power of error detection of Westgard multirules.

References 1. Zerbini M, Musiani M. Human parvoviruses. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology, 8th ed. Washington: ASM Press, 2003:1534–43. 2. Gallinella G, Zuffi E, Gentilomi G, Manaresi E, Venturoli S, Bonvicini F, et al. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases. J Med Virol 2003;71:135–9. 3. Tabor E, Epstein JS. NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion 2002;42: 1230–7. 4. Rasmussen R. Quantification on the LightCycler. In: Meuer S, Wittwer C, Nakagawara K, eds. Rapid cycle real-time PCR: methods and application. Berlin: Springer, 2001:21–34. 5. Mackay IM, Arden KE, Nitsche A. Real-time PCR in virology. Nucleic Acids Res 2002;30:1292–305. 6. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002–7. 7. Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 2002;67:275–81. 8. Harder TC, Hufnagel M, Zahn K, Beutel K, Schmitt H-J, Ullmann U, et al. New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections. J Clin Microbiol 2001;39:4413–9. 9. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 2001;92:183–91. 10. Gruber F, Falkner FG, Dorner F, Hammerle T. Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection. Appl Environ Microbiol 2001;67:2837–9. 11. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for validation of analytical procedures (Q2A) and methodology (Q2B). http:// www.ich.org. (Q2A, October 1995; Q2B, November 1996). 12. Saldanha J, Lelie N, Yu MW, Heath A. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002;82:24–31. 13. Gallinella G, Moretti E, Nardi G, Zuffi E, Bonvicini F, Bucci E, et al. Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay. Vox Sang 2002;83:324–31. 14. Siegl S, Cassinotti P. Presence and significance of parvovirus B19 in blood and blood products. Biologicals 1998;26:89–94.